Informations sur le produit
LP 533401 is a drug that has been shown to be effective in treating bowel disease. It has been used in treatment trials for metabolic disorders and has been shown to decrease hepatic steatosis, carcinoid syndrome, and inflammatory bowel disease. LP 533401 affects serotonin levels by inhibiting the production of serotonin from tryptophan and may also have a direct effect on serotonin receptors. This drug has been shown to have physiological effects such as systolic pressure, fetal bovine serum concentrations, and CD-1 mouse weight gain. The molecular docking analysis of this drug with serotonin receptor 1A (5HT1A) shows that it binds to the active site of the receptor and blocks its activity.
Propriétés chimiques
Question d’ordre technique sur : 3D-VMB97643 LP 533401
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
